Correlation Between Immix Biopharma and Immutep
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Immutep at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Immutep into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Immutep Limited, you can compare the effects of market volatilities on Immix Biopharma and Immutep and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Immutep. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Immutep.
Diversification Opportunities for Immix Biopharma and Immutep
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Immix and Immutep is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Immutep Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immutep Limited and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Immutep. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immutep Limited has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Immutep go up and down completely randomly.
Pair Corralation between Immix Biopharma and Immutep
If you would invest 157.00 in Immix Biopharma on September 14, 2024 and sell it today you would earn a total of 56.00 from holding Immix Biopharma or generate 35.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immix Biopharma vs. Immutep Limited
Performance |
| Timeline |
| Immix Biopharma |
| Immutep Limited |
Immix Biopharma and Immutep Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immix Biopharma and Immutep
The main advantage of trading using opposite Immix Biopharma and Immutep positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Immutep can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will offset losses from the drop in Immutep's long position.| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
| Immutep vs. Zura Bio Limited | Immutep vs. Enveric Biosciences | Immutep vs. Immix Biopharma | Immutep vs. Elevation Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |